Showing results (51-60 of 58) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
British Journal of Cancer|May 4, 2024
Targeting CXCR4 impaired T regulatory function through PTEN in renal cancer patientsSara Santagata, Giuseppina Rea, Anna Maria Bello, et al.Heliyon|August 22, 2024
CXCL12-loaded-hydrogel (CLG): A new device for metastatic circulating tumor cells (CTCs) capturing and characterizationLuigi Portella, Giulia Bertolini, Giuseppe Guardascione, et al.European Journal of Medicinal Chemistry|September 30, 2024
Comprehensive structural investigation of a potent and selective CXCR4 antagonist via crosslink modificationAnna Maria Trotta, Vincenzo Mazzarella, Michele Roggia, et al.Journal for Immunotherapy of Cancer|March 5, 2022
In PD-1+ human colon cancer cells NIVOLUMAB promotes survival and could protect tumor cells from conventional therapiesCaterina Ieranò, Dario Righelli, Crescenzo D'Alterio, et al.Cell Death Discovery|March 28, 2026
CXCR4, CXCR7 and PBRM1 are responsible for everolimus and cabozantinib resistance in human renal cancer cellsFederica Auletta, Caterina Ieranò, Dario Guido Di Febbraro, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2024
KIR2DL2/DL3+NKs and Helios+Tregs in Peripheral Blood Predict Nivolumab Response in Patients with Metastatic Renal Cell CancerSara Santagata, Anna Maria Trotta, Crescenzo D'Alterio, et al.Cancers|August 27, 2021
Prospective Evaluation of Radiotherapy-Induced Immunologic and Genetic Effects in Colorectal Cancer Oligo-Metastatic Patients with Lung-Limited Disease: The PRELUDE-1 StudyAlessandro Ottaiano, Angela Petito, Mariachiara Santorsola, et al.BMC Cancer|October 19, 2023
Oligo-metastatic neoPlasms from the gastro-intestinal tract: iDentIfiCaTIon of cliNical and molecular drivers: the PREDICTION studyAlessandro Ottaiano, Antonella De Luca, Mariachiara Santorsola, et al.Pageof 6